Pharma Journalist - Page 59 of 923 -

Gilead Completes $7.8 Billion Arcellx Acquisition Deal

EU Approves Rhapsido for Chronic Hives Treatment

Lilly to Acquire Ajax in $2.3 Billion Deal

AbbVie and IGI Ink Global Deal for First-in-Class Trispecific Antibody ISB 2001

Biocytogen Signs Antibody Licensing Deal with BeOne Medicines to Boost Drug Development

FDA Grants Orphan Drug Status to Adcentrx’s ADRX-0405 for Gastric Cancer

Neuraxpharm and Dizlin Partner to Develop Next-Gen Therapy for Advanced Parkinson’s Disease

KalVista’s EKTERLY Gets FDA Nod as First Oral On-Demand Hereditary Angioedema Treatment

GSK Completes Acquisition of Efimosfermin to Combat Steatotic Liver Disease

Sagent and Qilu Forge Strategic Partnership to Boost Access to Critical Injectables in U.S.

Chugai and Gero Partner to Develop Novel Age-Related Disease Therapies

Mustang Bio’s MB-101 Receives FDA Orphan Drug Designation for Astrocytomas and Glioblastoma

BioVersys and Shionogi Partner on Global NTM Drug Development Collaboration